Vident Advisory’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.01M | Buy |
33,158
+290
| +0.9% | +$35.1K | 0.05% | 324 |
|
|
2025
Q1 | $3.66M | Buy |
32,868
+7,531
| +30% | +$840K | 0.05% | 299 |
|
|
2024
Q4 | $2.47M | Buy |
25,337
+2,837
| +13% | +$276K | 0.04% | 365 |
|
|
2024
Q3 | $2.59M | Buy |
22,500
+3,457
| +18% | +$398K | 0.07% | 326 |
|
|
2024
Q2 | $2.03M | Buy |
19,043
+3,983
| +26% | +$424K | 0.06% | 365 |
|
|
2024
Q1 | $1.46M | Buy |
15,060
+1,834
| +14% | +$177K | 0.03% | 469 |
|
|
2023
Q4 | $1.34M | Buy |
13,226
+1,487
| +13% | +$150K | 0.03% | 479 |
|
|
2023
Q3 | $1.2M | Buy |
+11,739
| New | +$1.2M | 0.04% | 462 |
|